Molecular and Genetic Analysis of Lung Cancer

Mass General Brigham logo

Mass General Brigham

Status

Enrolling

Conditions

Lung Cancer

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT03029325
5P30CA006516-50 (U.S. NIH Grant/Contract)
1999P-004935

Details and patient eligibility

About

Investigators use a genome-wide approach within a case-control design to identify SNPs that show evidence of association with lung cancer risk and survival.

Full description

Investigators also investigate how genetic variants may affect cancer treatment, at various stages of disease development, in order to determine prognostic and predictive factors for survival.

Enrollment

12,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy controls: participants without evidence of any cancer
  • cases: pathology proven primary lung cancer

Exclusion criteria

  • younger than 18 years old

Trial contacts and locations

1

Loading...

Central trial contact

David Christiani, MD; Andrea Shafer, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems